Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Beijing Genomics Institute signs global site license with CLC bio for Next Generation Sequencing software platform

07 Jul 2008 - Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio's Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China.
 
Head of Bioinformatics Division at BGI, Ruiqiang Li states, "We have chosen CLC Genomics Workbench as our platform for analyzing Next Generation Sequencing data after testing several commercial solutions, because it's simply in a league of its own when it comes to flexibility and the way the Next Generation Sequencing tools can be used together with our own algorithms. In an organization of our size - with seventeen Illumina GA analyzers, as well as two AB/SOLiD and three Roche/454 Next Generation Sequencing machines, all of them running at full capacity - efficient workflows are of critical importance. We can support and expand our workflows by giving our scientists easy access via the Workbench to our own in-house developed algorithms. In no time, CLC Genomics Workbench has proved amazingly popular with our internal researchers, due to the fast, user-friendly and versatile platform it provides."